🔎 Trials Near Me

Akèy › BPCO › Maryland › Baltimore

Etid klinik pou BPCO nan Baltimore, MD

14 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3
  • Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
Laj 40 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT07190222

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Ap rekriteFaz 4
  • Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 2
  • Research Site, Baltimore
  • Research Site, Baltimore
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Ap rekriteFaz 2
  • Johns Hopkins University, Baltimore
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Ap rekriteFaz 3
  • Research Site, Baltimore
  • Research Site, Rosedale · 6 mi lwen
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Ap rekriteFaz 3
  • Research Site, Baltimore
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305

STRIVE Post-Market Registry Study

Ap rekriteEtid obsèvasyon
  • University of Maryland, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272

Multi-Center Clean Air Randomized Controlled Trial in COPD

Ap rekriteFaz 3
  • University of Maryland, Baltimore
  • Johns Hopkins, Baltimore
Laj 40 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06376994

SPIROMICS Study of Early COPD Progression (SOURCE)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Johns Hopkins Bayview Medical Center, Baltimore
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990

OMEGA - Dietary Intervention - COPD Trial

Ap rekrite
  • Johns Hopkins Bayview Campus, Baltimore
Laj 40 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT05297279

Trial to Determine Effective Aspirin Dose in COPD

Ap rekriteFaz 3
  • Johns Hopkins Bayview Medical Center, Baltimore
Laj 40 a 80 · Tout sèks · Mizajou Mar 16, 2026 · NCT05265299

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Ap rekriteEtid obsèvasyon
  • Johns Hopkins, Baltimore
Laj 21 a 100 · Tout sèks · Mizajou Sep 9, 2025 · NCT06751537

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Ap rekriteEtid obsèvasyon
  • Ascension St. Agnes Hospital, Baltimore
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Ap rekrite
  • University of Maryland - Baltimore, Baltimore
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888

Etid BPCO nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.